# 72205-136-91 · Lisdexamfetamine Dimesylate Tablet, Chewable · Novadoz Pharmaceuticals LLC — FDA drug shortage duration tracker For 72205-136-91 · Lisdexamfetamine Dimesylate Tablet, Chewable · Novadoz Pharmaceuticals LLC, package ndc is 72205-136-91; generic name is Lisdexamfetamine Dimesylate Tablet, Chewable; manufacturer is Novadoz Pharmaceuticals LLC; status is Current; availability now is Available, recorded from its source on 2026-09-01. - **Package NDC:** 72205-136-91 _(verified: appears in the quote below)_ - **Generic name:** Lisdexamfetamine Dimesylate Tablet, Chewable _(verified: appears in the quote below)_ - **Manufacturer:** Novadoz Pharmaceuticals LLC _(verified: appears in its own passage below)_ - **Status:** Current _(verified: appears in its own passage below)_ - **Availability now:** Available _(verified: appears in the quote below)_ - **Initial posting date:** 07/14/2023 _(verified: appears in the quote below)_ - **Last update date:** 08/17/2026 _(verified: appears in its own passage below)_ - **Days in shortage:** 1145 _(our reading, not quoted from the source)_ - **Dosage form:** Tablet, Chewable _(verified: appears in its own passage below)_ - **Therapeutic category:** Psychiatry _(verified: appears in its own passage below)_ ## What the source says > "initial_posting_date": "07/14/2023", "package_ndc": "72205-136-91", "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable", "contact_info": "(855) 668-2369; customerservice@novadozpharma.com", "availability": "Available" ## Where each value comes from This source states these in separate places, so each value is shown with the passage that states it. ### Manufacturer > "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet, Chewable", "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91)", "company_name": "Novadoz Pharmaceuticals LLC", "status": "Current" ### Status > "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet, Chewable", "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91)", "company_name": "Novadoz Pharmaceuticals LLC", "status": "Current" ### Last update date > "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet, Chewable", "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91)", "company_name": "Novadoz Pharmaceuticals LLC", "status": "Current" ### Dosage form > "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet, Chewable", "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91)", "company_name": "Novadoz Pharmaceuticals LLC", "status": "Current" ### Therapeutic category > "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet, Chewable", "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91)", "company_name": "Novadoz Pharmaceuticals LLC", "status": "Current" ## Source - https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novadoz%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000 Last verified: 2026-09-01. Review by: 2026-09-04. Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).